Lambert Eaton myasthenic syndrome is
**Core Concept**
Lambert Eaton myasthenic syndrome (LEMS) is a rare autoimmune disorder characterized by the presence of autoantibodies against the voltage-gated calcium channels (VGCCs) at the neuromuscular junction. This results in impaired neurotransmitter release and subsequent muscle weakness.
**Why the Correct Answer is Right**
The autoantibodies in LEMS target the P/Q-type VGCCs, specifically the alpha1A subunit, which is essential for the release of acetylcholine from the motor nerve terminals. This leads to a reduction in acetylcholine release, resulting in muscle weakness and fatigue. The clinical presentation of LEMS often includes symptoms such as proximal muscle weakness, autonomic dysfunction, and areflexia.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because LEMS is not primarily associated with an increase in acetylcholine release, but rather a decrease due to impaired calcium channel function.
**Option B:** This option is incorrect because LEMS does not primarily involve a defect in the nicotinic acetylcholine receptors, but rather a defect in the voltage-gated calcium channels.
**Option C:** This option is incorrect because myasthenia gravis is a distinct autoimmune disorder characterized by autoantibodies against the nicotinic acetylcholine receptors, not the voltage-gated calcium channels.
**Clinical Pearl / High-Yield Fact**
LEMS often presents with a distinctive clinical picture, including proximal muscle weakness, autonomic dysfunction, and areflexia. It is essential to consider LEMS in the differential diagnosis of patients with subacute or chronic muscle weakness, particularly those with a history of exposure to certain medications, such as aminoglycosides or penicillamine.
**Correct Answer: D. Autoimmune disorder characterized by autoantibodies against voltage-gated calcium channels.**